본문 바로가기
intron logo

logo

  • About us
    • BUSINESS
    • R&BD HISTORY
    • OUR EXPERTISE
    • OUR PEOPLE
    • INSIDE iNtRON
  • Platform
    • TECHNOLOGY OVERVIEW
    • PHAGERIARUS®
    • PHAGERUS®
    • PHAGERIA®
    • itLysin®
    • im-MucoDr®
  • AD / BC
    • AD / BC
    • Triangle Hypothesis
  • B.E.C. Project
    • B. E. C. PROJECT
  • Partnering
    • PARTNERING
    • CONTACT
  • Address.

    iNtODEWORLD
    1500 District Avenue,
    Suite 2097, Burlington, MA 01803, USA

    iNtRON Biotechnology
    Suite 701~704, 137, Sagimakgol-ro, Jungwon-gu,
    Seongnam-si, Gyeonggi-do, Republic of Korea

  • Email.

    partner@intron.co.kr

  • Immune System Regulation By Bacteriophages

    25 August,2021
  • Bacteriophage Technology, from Infectious Disease to Anticancer Therap

    06 April,2021
  • Microbiome – Massive Expansion of Human Gut Bacteriophage Diversity

    14 March,2021
  • ‘Bacteriophages’, a Game Changer in COVID-19

    10 January,2021
  • Global Trend in Clinical Success of Universal Influenza Vaccine

    28 December,2020
  • A New Concept of Post-COVID-19 Vaccine Platform with PHAGERUS® Technol..

    16 December,2020
  • Human Health and Gut Phageome

    18 November,2020
  • [Promotional Video] LiliF™ GBN COVID-19 IgG Rapid Kit

    27 August,2020
  • iNtRON Biotechnology, Inc. attended the 38th Annual J.P. Morgan Health..

    21 January,2020
  • Challenges faced in the CRO industry as drug development advances to t..

    20 January,2020
1 2 3 4
  • Address.
    iNtODEWORLD
    1500 District Avenue,
    Suite 2097, Burlington, MA 01803, USA
    iNtRON Biotechnology
    Suite 701~704, 137, Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
  • Email.
    partner@intron.co.kr

(C) 2022. iNtODEWORLD. Inc. All rights reserved.